Medical devices, healthcare technology and the business of care
510(k) clearance · K252854

SteriTite Container System with MediTray Products

Case Medical, Inc. · Decision date Jun 3, 2026

FDA DECISIONK252854

What did the FDA decide?

FDA records K252854 as a 510(k) premarket notification, with a decision dated Jun 3, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Jun 3, 2026

FDA source record

Regulatory record facts

Identifier
K252854
Regulatory pathway
510(k) premarket notification
Product code
KCT
Decision code
SESE
Decision date
Jun 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sterilization Wrap Containers, Trays, Cassettes & Other Accessories.

Product code
KCT
FDA device class
2

FDA decision timeline

  1. K252854 received

    Application receipt date recorded by FDA.

  2. K252854 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KCT

Product / regulatory recordCompanyPathwayDecision dateSource
S.I.N. Implant System Ltda510(k) clearanceOct 22, 2026FDA
Alliedstar Medical Equipment Co., Ltd.510(k) clearanceOct 14, 2026FDA
Nobel Biocare AB510(k) clearanceSep 8, 2026FDA
Dentsply Sirona, Inc.510(k) clearanceSep 4, 2026FDA
Mastel Surgical510(k) clearanceJun 18, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Case Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Bloomfield, NJ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records